Protection from Overprescribing Act

Bill: 115-s-2451
Sponsor: full_name: Sen. Cassidy, Bill [R-LA]
Introduced: 2018-02-26
Policy area: Health
Latest action: action_date: 2018-02-26
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2018-02-26
action_desc: Introduced in Senate
text: <p><strong>Protection from Overprescribing Act</strong></p> <p>This bill requires the Department of Health and Human Services to consider when awarding a grant to a state to support the state's prescription drug monitoring program whether the state's program provides reports to law enforcement agencies, licensing boards, and other agencies describing any prescribers who repeatedly fall outside of expected norms or standard practices.</p>

tv_txt: II 115th CONGRESS 2d Session S. 2451 IN THE SENATE OF THE UNITED STATES February 26, 2018 Mr. Cassidy introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To require the Secretary of Health and Human Services to consider State analysis and sharing of prescription drug monitoring program data in determining prescription drug monitoring program grants to States.

1. Short title This Act may be cited as the Protection from Overprescribing Act . 2. Consideration in awarding grants to support State PDMPs In determining whether to award a grant to a State in support of a State prescription drug monitoring program, the Secretary of Health and Human Services shall consider whether each agency of the State that administers the prescription drug monitoring program pro­ac­tively analyzes data available through the State’s prescription drug monitoring program and provides reports to law enforcement agencies, prescriber licensing boards, and other agencies describing any prescribers that repeatedly fall outside of expected norms or standard practices for the prescriber’s field.